Table 3. Multivariate regression analysis for the effect of EFV on hemodynamically significant CAD.
| Variables | Nonadjusted | Adjusted I | Adjusted II | |||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |||
| EFV (per 10 cm3) | 1.36 (1.20–1.55) | <0.001 | 1.46 (1.20–1.77) | <0.001 | 1.53 (1.25–1.88) | <0.001 | ||
| Tertiles | ||||||||
| Bottom tertile (events/n=9/55) | 1 | 1 | 1 | |||||
| Middle tertile (events/n=20/54) | 3.01 (1.22–7.42) | 0.02 | 2.57 (0.83–7.95) | 0.10 | 3.35 (1.00–11.20) | 0.049 | ||
| Top tertile* (events/n=33/55) | 7.67 (3.13–18.77) | <0.001 | 10.00 (2.76–36.24) | <0.001 | 17.32 (3.95–75.89) | <0.001 | ||
Adjusted I, model adjusted for BMI, hypertension, DM, symptom, and coronary artery calcium prevalence; Adjusted II, model adjusted for age, gender, BMI, hypertension, DM, active smoking, hyperlipidemia, symptom, and coronary artery calcium prevalence; *, P for trend <0.001. EFV, epicardial fat volume; CAD, coronary artery disease; OR, odds ratio; CI, confidence interval.